LYKA LABS   
                    
                    
                                                         
                                
                                                                 Back to All Ratios 
                                                
                     | 
                        
                        
                        
                        
                    
LYKA LABS Last 5 Year Working Capital/Sales History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Working Capital/Sales(x) | 6.66 | 8.63 | 8.02 | -4.12 | -4.15 | 
What is the latest Working Capital/Sales ratio of LYKA LABS ?
| Year | Working Capital/Sales | 
|---|---|
| Mar2025 | 6.66 | 
| Mar2024 | 8.63 | 
| Mar2023 | 8.02 | 
| Mar2022 | -4.12 | 
| Mar2021 | -4.15 | 
How is Working Capital/Sales of LYKA LABS Trending?
| Years | Working Capital/Sales | % Change | |
|---|---|---|---|
| Mar2025 | 6.66 | -22.83 | |
| Mar2024 | 8.63 | 7.61 | |
| Mar2023 | 8.02 | Positive | |
| Mar2022 | -4.12 | Negative | |
| Mar2021 | -4.15 | - | |
Other Financial Ratios of LYKA LABS
| Operational &  Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate  | Margin  Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin  | Performance  Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset  | Efficiency  Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days  | Valuation  Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales  | Growth  Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth  | Financial Stability  Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap  | 
Compare Working Capital/Sales ratio of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹338.8 Cr | 0.5% | -3% | -34.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,147.0 Cr | 1.2% | 4.4% | -9.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,488.0 Cr | 5.8% | 19.2% | 16.3% | Stock Analytics | |
| CIPLA | ₹121,452.0 Cr | -3.7% | -0.2% | 1.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,057.0 Cr | 1.4% | 1.8% | 10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,220.0 Cr | -7.3% | -4% | -6.1% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year | 
| LYKA LABS |    0.5%  | 
                            
                     
                     -3%  | 
                     
                     -34.4%  | 
                    
| SENSEX |    -1.4%  |    
                      
                    
                     3.1%  | 
                     
                     3.8%  | 
                    
You may also like the below Video Courses